This Biomanufacturing Hub is a Star in Philly’s Top-Tier Gene Therapy Scene

Philadelphia is one of the top cell and gene therapy hubs in the US, and Audrey Greenberg is at the forefront.

In 2019, Audrey and her team identified an opportunity to convert a former GSK R&D headquarters in King of Prussia into a biomanufacturing center of excellence.

Center for Breakthrough Medicines (CBM) has since become a leading contract development and manufacturing organization within the region’s burgeoning life sciences community. CMB specializes in cell and gene therapy and partners with pharmaceutical companies to bring their products from the conceptual stage to the market.